Accelerating Global Health Progress
Whatever the future may bring, the world depends on improved global health to continue to promote prosperity and enable human progress. The R&D-based biopharmaceutical industry is committed to innovate and partner to deliver better health for everyone, everywhere.
Continuing on from the last World Health Assembly’s event to mark its 50th anniversary, the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) convenes public health experts to discuss the future of global health, and more specifically how we can better work together towards greater global health progress in the future.
The event will bring together government decision-makers and leading players in the field of global health to explore how to strengthen health systems so that they become agile and ready to respond to health security threats and make Universal Health Coverage truly universal. As the World Health Organization Director General, Dr. Tedros, says “health security and universal health coverage are two sides of the same coin” and the key to success is partnerships.
Dr Peter Salama
Deputy Director-General, World Health Organization
Mr Ian C Read
Chairman and CEO, Pfizer, President, IFPMA